Though not all scars act the same way, scarring is a normal result of wound healing. Abnormal scars like keloids and hypertrophic scars can turn persistent clinical and emotional issues for patients on the face — where visibility, skin tension, and aesthetics are intimately linked.
Although both scar kinds include extra collagen formation, they vary in behavior, treatment response, and long-term prognosis. Especially in facial areas where function and look are hard to separate, correct diagnosis and a focused treatment strategy are vital.
Dr. Kristina Zakhary of Facial Cosmetic Surgery looks at scar management from the perspective of both cosmetic result and reconstructive accuracy. Having considerable knowledge, skills and expertise in facial plastic and reconstructive surgery, she provides patients with thorough assessment, medical-surgical planning, and individualized treatment for these difficult scar kinds.
The defining features of keloid and hypertrophic scars are described in this paper together with their causes and evidence-based management strategies for clinical facial practice.
Every scar starts as a wound. The body starts a healing process once the dermis is damaged — by trauma, acne, surgery, or burns. Collagen fibres in normal healing reconstruct the skin matrix and progressively taper off as the tissue strengthens.
In keloid and hypertrophic scarring, collagen synthesis continues past its appropriate time. Rather, it runs unchecked and causes a raised, thick, and sometimes discolored scar.
Although the underlying cause — a disturbance to the dermal layer — may be the same, the results vary depending on a mix of genetics, skin type, wound tension, location, and immune response.
Though they can happen anywhere on the body, both kinds are more likely to form on the face in high-tension areas: jawline, chin, cheeks, temples, and earlobes.
Often following piercings, lacerations, or surgeries like facelifts or mole removals, keloids are especially prevalent on the mandibular border and earlobes.
During an initial consultation, Dr. Kristina Zakhary conducts a comprehensive evaluation to determine the scar type, maturity, and response to prior treatments.
Assessment includes:
Precise classification is vital, as misidentifying a keloid as a hypertrophic scar — or vice versa — can lead to treatment failure or worsening.
Facial scars are uniquely prone to hypertrophic and keloid change for three reasons:
Additionally, facial acne scars — especially cystic lesions on the cheeks or jaw line — can evolve into hypertrophic scars or keloid nodules even without obvious trauma.
Managing facial keloids and hypertrophic scars requires a multi-modal strategy. No single method guarantees success, particularly with keloid scars, which carry a recurrence rate of up to 70–90% without adjunctive treatment.
Dr. Zakhary’s treatment plans are customized based on scar type, skin type, and patient priorities. Her philosophy prioritizes function preservation, long-term recurrence prevention, and aesthetic refinement in equal measure.
Corticosteroids (often triamcinolone) are injected directly into the scar tissue to:
Most effective in early hypertrophic scars or smaller keloids. Injections are spaced 4–6 weeks apart, with 3–5 sessions typically required.
Fractional ablative lasers (CO₂) and pulsed dye lasers (PDL) can reduce redness, stimulate collagen remodelling, and improve scar pliability. Laser treatment is most successful on hypertrophic scars or residual post-surgical scarring.
Dr. Zakhary often combines laser resurfacing with topical therapies to enhance penetration and healing.
Medical-grade silicone applied as a gel or flexible sheet creates a hydrated microenvironment that:
Best used preventively post-procedure or alongside early treatment.
Surgical revision is considered when:
In hypertrophic cases, Dr. Zakhary may excise the scar and perform a layered closure along natural tension lines, often employing Z-plasty, Geometric broken line or W-plasty to break up linear tension and improve camouflage.
Keloid surgery is never performed in isolation. Due to the high recurrence rate, it is always paired with:
Close follow-up is critical. Recurrence often begins within 2–6 weeks if untreated.
Patients with a history of keloid or hypertrophic scarring require proactive care, even after successful treatment.
Dr. Zakhary provides structured follow-up that includes:
No scar can be removed completely. But under expert care, the volume, texture, discolouration, and contour of a keloid or hypertrophic scar can be significantly improved — often to the point of being barely visible in normal lighting.
Patients are counselled about recurrence risk, especially with keloids, and are involved in every decision point of the care plan.
Facial keloid and hypertrophic scars present complex challenges that extend beyond appearance. They can cause discomfort, restrict movement, and erode self-confidence. Effective management demands both medical precision and aesthetic sensitivity — especially when treating the face.
At Facial Cosmetic Surgery, Dr. Kristina Zakhary applies years of subspecialty head and neck surgery training in facial plastic and reconstructive surgery to offer patients comprehensive scar assessment and treatment. Whether through precision excision, advanced laser therapy, or layered steroid regimens, her goal is clear: to restore comfort, function, and natural contour — one patient at a time.